NCT06223984View on ClinicalTrials.gov

Combined Use of Immunoglobulin and Pulse Steroid Therapies in Severe Covid-19 Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

March 30, 2020

Primary Completion Date

November 14, 2020

Study Completion Date

November 14, 2020

Conditions
Pulse Steroid and Immunoglobulins Drugs in Covid 19 Patients
Interventions
DRUG

pulse steroid and nanogam

patients received pulse steroid and ivig treatments in addition to standard treatment.

Trial Locations (1)

42020

Konya City Hospital, Konya

All Listed Sponsors
lead

Konya City Hospital

OTHER

NCT06223984 - Combined Use of Immunoglobulin and Pulse Steroid Therapies in Severe Covid-19 Patients | Biotech Hunter | Biotech Hunter